• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Restenosis (4576)
Event Date 01/19/2020
Event Type  Injury  
Manufacturer Narrative
Journal article title: safety and efficacy of conservative, endovascular bare stent and endovascular coil assisting bare stent treatments for patients diagnosed with spontaneous isolated superior mesenteric artery dissection interventional radiology/vascular surgery videosurgery and other miniinvasive techniques 4, december/2020 videosurgery miniinv 2020; 15 (4): 608¿619 doi: https://doi.Org/10.5114/wiitm.2020.92403.Date of publication online.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a study to evaluate the safety and efficacy of conservative, endovascular bare stent and endovascular coil assisting bare stent treatments for patients diagnosed with spontaneous isolated superior mesenteric artery dissection (sismad).62 patients were included in the study.Medtronic bare self-expanding stents were implanted.Within the stenting group (39 patients) and the stenting and coiling group (9 patients) technical success is reported in 97.4% and 100% of cases respectively.1 failure is reported in the stenting group where a secondary treatment was required.In the case with the reported failure, the patient underwent fasting and was discharged from the hospital after 5 days.Eleven days after discharge, the patient was readmitted with recurrence of symptoms, cta was performed, and restenosis was revealed.The patient was kept under observation for 2 days in which symptoms persisted then secondary treatment was performed whereby a 7 mm by 21 mm stent was deployed successful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11326861
MDR Text Key234905188
Report Number2183870-2021-00067
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 02/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2021
Initial Date FDA Received02/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-